MedTrace Logo

Deep Serratus Anterior Plane Block vs Surgically-placed Paravertebral Block for VATS Surgery

NCT03768193 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-12-07

No results posted yet for this study

Summary

Thoracic surgery, and surgery involving the chest wall in general, is associated with poorly controlled acute pain, which may result in delayed functional recovery, and may progress to chronic pain. Multimodal opioid-sparing analgesia regimens are a key component of the thoracic surgery enhanced recovery pathway, the aim of which is to improve outcomes in patients undergoing both minimally invasive and open thoracic surgical procedures. Novel interfascial plane blocks are emerging as feasible alternatives to central neuraxial analgesia techniques in a variety of clinical settings.

The aim of this study is to show non-inferiority of serratus anterior blockade compared with surgically placed paravertebral blocks in the management of perioperative acute pain in patients undergoing VATS procedures.

Conditions

  • Thoracic Diseases
  • Thoracic Surgery
  • Rib Fractures
  • Pain, Postoperative
  • Pain, Procedural
  • Anaesthesia, Regional

Interventions

PROCEDURE

Deep serratus anterior plane block

Deposition of local anaesthetic in the space between the serratus anterior muscle and the external intercostal muscle, at the level of the 4th-5th rib, in the midaxillary line. Procedure performed under ultrasound guidance. Catheter - based infusion of local anaesthetic into this space for 48 hours.

PROCEDURE

Surgically-placed paravertebral block

Surgically-placed paravertebral block catheters for continuous local anaesthetic infusion of 0.125% levobupivacaine at 8-12mls/ hr for 48 hours.

Sponsors & Collaborators

  • Mater Misericordiae University Hospital

    lead OTHER

Principal Investigators

  • Conor Hearty, FFPMCAI,FFPMANZCA,FCARCSI,FIPP · Consultant Anaesthetist, Mater Misericordiae University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-04
Primary Completion
2018-09-01
Completion
2018-09-01

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03768193 on ClinicalTrials.gov